Hepatitis Forums
Advanced Liver Disease Main Forums => Advanced Liver Disease => Topic started by: Hep Editors on December 12, 2018, 10:37:13 am
-
A recent study showed no difference in the rate of hepatocellular carcinoma (HCC, the most common form of liver cancer) recurrence based on the type of hepatitis C virus (HCV) treatment received, Healio reports.
Some controversy persists among members of the hep C research community as to whether those who have had liver cancer and receive HCV treatment are in fact at lower risk of liver cancer if they receive the older treatment of interferon compared with taking the newer direct-acting antivirals (DAA). Multiple recent studies have refuted this presumption.
Read more...
https://www.hepmag.com/article/hep-c-treatment-type-tied-liver-cancer-recurrence-risk